acquisitions
University of Edinburgh spinout Kynos Therapeutics acquired by Dr. Falk Pharma
October 30, 2024Research and Development Edinburgh, Internal Medicine, Microbiology, acquisitions, biopharma, inhibitors
Kynos Therapeutics – a Scottish clinical stage biopharma company focusing on developing novel kynurenine 3-monooxygenase (KMO) inhibitors – has been …
Bayer buys BlueRock Therapeutics for $600 million
August 9, 2019Medical Communications Bayer, BlueRock, acquisitions, cell therapies, pharma
Bayer has entered into an agreement to fully acquire engineered cell therapy firm BlueRock Therapeutics in a deal worth $600 …
Scottish borders-based Ryboquinn acquires viral delivery comany Nanogenics
July 20, 2018Medical Communications M&A, MA, Scotland, acquisitions, gene therapy, nanogenics, ryboquinn
The Scottish biotech company Ryboquinn has acquired English partner Nanogenics Solutions in a deal worth £4.45 million. The Selkirk-based firm …
Takeda reportedly sets $15bn on US acquisitions
September 14, 2016Manufacturing and Production, Research and Development Takeda, acquisitions
Takeda Pharmaceuticals is reportedly willing to spend as much as $15 billion on acquisitions in the US in efforts to …
MSD to acquire Scottish firm IOmet Pharma
January 12, 2016Research and Development, Sales and Marketing IOMet Pharma, MSD, Merck, Scotland, acquisitions, immuno-oncology, mergers, oncology
US pharma company MSD is to buy Edinburgh based IOMet Pharma to expand its existing R&D programme, exploring the development …
Alliance Pharma buys Sinclair’s healthcare products business for £132m
December 17, 2015Manufacturing and Production, Sales and Marketing Alliance Pharma, Sinclair IS Pharma, acquisitions, dermatology merger
Alliance has completed a £132 million purchase of Sinclair IS Pharma’s non-aesthetics healthcare business as it moves to strengthen its …
AstraZeneca to buy majority share in Acerta Pharma
December 17, 2015Sales and Marketing Acerta Pharma, AstraZeneca, acalabrutinib, acquisitions, mergers
Following several days of speculation, AstraZeneca has announced that it has agreed a deal to buy Acerta Pharma, a developer …
AstraZeneca in $5bn Acerta buyout talks
December 14, 2015Sales and Marketing Acerta Pharma, AstraZeneca, acalabrutinib, acquisitions, blood cancer, buyout, chronic lymphocytic leukaemia, mergers, takeover
AstraZeneca has confirmed it is in negotiations to buy cancer drug developer Acerta Pharma BV for more than $5 billion …
Five benefits and challenges of the Pfizer/Allergan mega-merger
December 7, 2015Manufacturing and Production, Research and Development, Sales and Marketing Allergan, Pfizer, acquisitions, mergers, takeovers
Pfizer was extremely keen to get the $160 billion deal done, but what is it getting out of the acquisition, …
Teva strips $1 billion worth of assets to clear Allergan deal
December 4, 2015Medical Communications, Sales and Marketing Allergan, Teva, acquisitions, divestments, mergers
Teva Pharmaceuticals is thought to be in the process of stripping nearly $1 billion worth of assets to address antitrust …
Merck KGaA completes $17bn Sigma-Aldrich acquisition
November 18, 2015Manufacturing and Production, Sales and Marketing M&A Sigma Aldridge, Merck, acquisitions, mergers
Merck KGaA has announced the completion of its $17 billion acquisition of Sigma-Aldrich, having cleared the final regulatory hurdle and …
LEO Pharma buys dermatology portfolio from Astellas
November 12, 2015Sales and Marketing Astellas, LEO Pharma, acquisitions, dermatology, mergers
LEO Pharma, the speciality dermatology firm, is looking to expand its presence in the therapy area by buying Astellas’ portfolio …
AstraZeneca acquires ZS Pharma for $2.7bn, announces Q3 results
November 6, 2015Medical Communications AstraZeneca, M&A, MA, ZS Pharma, ZS-9, acquisitions, financial results, hyperkalaemia, mergers
AstraZeneca has announced its acquisition of ZS Pharma for an all-cash total of $2.7 billion. In the latest mega-money deal …
2015’s top five mergers and acquisitions in a record-breaking year
October 19, 2015Sales and Marketing Deals, acquisitions, mergers, pharma, takeovers
A new report from analysts MergerMarket reveals that mergers and acquisitions so far in 2015 have surpassed the same 2014 …
Mylan to relaunch $27.1bn hostile takeover of Perrigo
September 10, 2015Sales and Marketing Mylan Perrigo, acquisitions, hostile bid, mergers, takeover
Mylan is to make yet another hostile $27.1 billion bid for Irish over the counter drug manufacturer Perrigo on Monday, …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
